Other
GIP-A
GIP-A is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor
NCT03807076
completednot_applicable
Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)
NCT03013296
completednot_applicable
Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist
NCT03133741
completednot_applicable
GIP Receptor Antagonist Studies in Humans
NCT02747472
Clinical Trials (4)
Showing 4 of 4 trials
NCT03807076Not Applicable
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor
NCT03013296Not Applicable
Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)
NCT03133741Not Applicable
Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist
NCT02747472Not Applicable
GIP Receptor Antagonist Studies in Humans
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4